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ABSTRACT
Diabetes rates are on the rise, particularly among members of racial and ethnic
minority groups. Individuals with diabetes are more vulnerable to developing depressive
symptoms when compared to those without diabetes. While there appear to be no racial
and ethnic differences in depression prevalence estimates among individuals with
diabetes, members of racial and ethnic minority groups are less likely to achieve
glycemic control over time, and may be at greater risk for diabetes related health issues.
One such health issue is sexual dysfunction, with individuals with diabetes being
more vulnerable to sexual dysfunction than those without diabetes. Sexual dysfunction
may have significant biopsychosocial impacts on an individual’s ability to manage their
diabetes. However, the potential impact of sexual dysfunction on glycemic control is still
unclear. Possible racial and ethnic differences in the prevalence of sexual dysfunction
among individuals with diabetes are unknown. The relationship between, and potential
long-term impact of, depression and sexual dysfunction on glycemic control has received
very little attention in the diabetes research literature. This study sought to address this
gap in the literature, as well as contribute more information regarding possible racial and
ethnic differences in outcomes among individuals with diabetes by examining racial
differences in glycemic control, the prevalence of depression and sexual dysfunction, and
the longitudinal impact of these disorders on glycemic control among a national sample
of veterans. Racial and ethnic differences in prevalence of depression and sexual
dysfunction were expected. Additionally, significant individual and interactive impacts of
iv

race and depression/sexual dysfunction status on glycemic control over time were
expected.
Data from 50,039 veterans with diabetes were included in the current
investigation. Relevant data were extracted from the Veteran’s Affairs (VA) Informatics
and Computing Infrastructure (VINCI), which is partnered with the Corporate Data
Warehouse (CDW) that manages VA patient health records. Veterans were classified as
depressed or experiencing sexual dysfunction based on ICD-9 codes for depression and
sexual dysfunction. General linear mixed model regression analyses were conducted
examine changes over time, represented by age, in A1C levels among the different
diagnostic groups. Post-hoc curvilinear analyses of longitudinal models were also
conducted.
The findings revealed racial and ethnic differences in the prevalence of depression
and sexual dysfunction among veterans with diabetes, with White American veterans
having higher percentage rates of depression (phi = .02) and Black American veterans
having higher percentage rates of sexual dysfunction (phi = .12). Findings for both linear
and curvilinear analyses of longitudinal models also revealed significant differences in
A1C levels across racial and ethnic groups, as well as diagnostic groups, over time.
Specifically, Black American veterans and veterans with sexual dysfunction exhibited
decreasing mean A1C levels over time while White American veterans and veterans with
no diagnosis exhibited gradually increasing mean A1C levels over time. Significant racial
and ethnic differences in A1C levels were also present among veterans with depression.
Findings suggest possible impact of race, sexual dysfunction, and depression on longterm glycemic control. Implications of the findings are discussed.
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CHAPTER 1
INTRODUCTION
Due to continually rising prevalence rates of diabetes in the last decade, there has
been a strong and persistent increase in diabetes research. The Centers for Disease
Control (CDC) estimates that diabetes affects nearly 26 million people in the United
States, meaning that about eight percent of the U.S. population has diabetes (CDC, 2011).
The majority of persons with diabetes have either type 1 or type 2 diabetes, although
other types of diabetes are recognized (e.g., gestational diabetes or diabetes resulting
from a specific genetic or medical condition) (CDC, 2011).
Type 1 diabetes accounts for 5% to 10% of all diagnosed cases of diabetes in
adults, and develops when the body's immune system destroys pancreatic beta cells
(CDC, 2011). Since these are the only cells in the body that make insulin, people with
type 1 diabetes must have insulin delivered by injection or a pump in order to survive
(CDC, 2011). Type 2 diabetes is more common than type 1 diabetes, accounting for
about 90% to 95% of all diagnosed cases in adults. It usually begins as insulin resistance,
a disorder in which the cells do not use insulin properly; as the need for insulin rises, the
pancreas gradually loses its ability to produce the hormone. Type 2 diabetes is associated
with a number of risk factors, including older age, obesity, family history of diabetes,
history of gestational diabetes, impaired glucose metabolism, and physical inactivity
(CDC, 2011).
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Members of racial and ethnic minority groups are at high risk for diabetes. After
adjusting for population age differences, a 2007–2009 national survey of persons aged 20
years or older indicated that 7.1% of non-Hispanic Whites, 8.4% of Asian Americans,
11.8% of Hispanics, and 12.6% of non-Hispanic Blacks had been diagnosed diabetes.
Among all non-White Hispanics surveyed, rates were 7.6% for both Cubans and for
Central and South Americans, 13.3% for Mexican Americans, and 13.8% for Puerto
Ricans (CDC, 2011). Members of racial and ethnic minority groups, particularly Black
Americans, are also at greater risk for experiencing medical complications due to
diabetes when compared to White Americans (CDC, 2011).
Such prevalence rates are problematic due to their associated health risks. Adults
with diabetes have heart disease death rates about 2 to 4 times higher than adults without
diabetes, and the risk for stroke is 2 to 4 times higher among people with diabetes (CDC,
2011). Also, diabetes is the leading cause of new cases of blindness among adults and is
the leading cause of kidney failure, accounting for 44% of new cases in 2008 (CDC,
2011). Furthermore, about 60% to 70% of all persons diagnosed with diabetes have mild
to severe forms of nervous system damage, as severe forms of diabetic nerve disease is a
major contributing cause of lower-extremity amputations (CDC, 2011). Given these data,
and as prevalence rates continue to rise, diabetes is clearly a serious medical condition
that continues to significantly impact the American people.
Diabetes and Depression
While diabetes increases the risk of many physical health conditions, research
suggests that patients with diabetes may also be at risk for co-morbid mental health
issues, especially depression. The results of a meta-analytic investigation of 42 studies
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indicated that the odds of depression among diabetics was twice that of the non-diabetic
comparison group, a finding that was not contingent upon gender, type of diabetes,
subject source, or assessment method (Anderson, Freeland, Clouse, & Lustman, 2001).
The results of a more recent meta-analysis of ten controlled studies also suggested that
the prevalence of depression was significantly higher in patients with type 2 diabetes
compared with those without, with the prevalence of depression being higher among
females with type 2 diabetes compared to males with diabetes (Ali, Stone, Peters, Davies,
& Khunti, 2006). Fisher, Skaff, Mullan, Arean, Glasgow, and Masharani (2008)
explored the prevalence of affective disorders, depressive affect, and diabetes- specific
emotional distress (i.e., negative emotions towards diabetes and its treatment) over time
among 506 patients with type 2 diabetes. They found that patients with type 2 diabetes
displayed high rates of affective disorders over an 18-month period, relative to
community adults. Specifically, patients with diabetes had 60% higher rates for major
depressive disorder and 7% higher rates for dysthymia (persistent depressive episodes
lasting longer than two years) compared to community adults without diabetes, with
women and younger patients being at high risk for both conditions over time (Fisher et
al., 2008).
deGroot, Pinkerman, Wagner, & Hockman (2006) found no differences in
depression scores between racial and ethnic groups or diabetes type, but results also
suggested that Black Americans were less likely to report any depression treatment,
receipt of antidepressant medications, or receipt of treatment from a mental health
professional compared to White Americans. Wagner, Tsimikas, Heapy, de Groot, and
Abbott (2007), reported similar findings in a study in which scores for depressive
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symptoms were similar among White American, Black American, and non-White
Hispanic patients with diabetes. However, Black Americans reported lower rates of
physician-diagnosed depression than White Americans, and those Black Americans who
endorsed depressive symptoms reported marginally lower rates of pharmacotherapy than
White Americans.
Overall, the results of these studies indicate that the prevalence of depression
appears to be higher among patients with diabetes when compared to the general
population. While there do not appear to be racial and ethnic differences in depression
scores among diabetes patients, depression may often go undiagnosed in Black American
diabetes patients. Black Americans are also less likely to receive treatment for depression
when compared to White Americans. These issues may be related to racial and ethnic
differences in the presentation of depressive symptoms, with Black Americans endorsing
more somatic symptoms than affective symptoms or changes in mood when compared to
White Americans (Baker, Okwumabua, Philipose, & Wong, 1996; Brown, Schulberg, &
Madonia, 1996; Das, Olfson, McCurtis, & Weissman, 2006). This presentation may lead
to providers to assume that there is only a physical health issue that needs to be treated
and not a psychological issue. There are also racial and ethnic differences in attitudes
about treatment for depression. A recent study of older Americans (individuals over age
60) revealed that depressed older adults endorsed a high level of public stigma about
mental health treatment, and were not likely to be currently engaged in or seek mental
health treatment for their depression (Conner, Copeland, Grote, Koeske, Rosen, et al.
2010). The also found that Black American older adults were more likely to internalize
stigma and endorsed less positive attitudes toward seeking mental health treatment than
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their White American counterparts. Such findings highlight the importance of
understanding the impact of depression within a diabetes population, possibly paying
particular attention to Black Americans to ensure accurate diagnosis and treatment of
their depression.
Impact of Diabetes and Depression on Physical Health
Given the high prevalence of depression among patients with type 1 and type 2
diabetes, there has been a growing interest in how depression impacts diabetes-related
health complications and medical outcomes. The results of one meta-analytic
investigation revealed a significant association between depression and a variety of
diabetes complications among patients with type 1 and type 2 diabetes, including diabetic
retinopathy, nephropathy, neuropathy, macrovascular complications, and sexual
dysfunction (de Groot, Anderson, Freedland, Clouse, & Lustman, 2001). Other study
results indicate that individuals with diabetes and depression report a poorer quality of
life, including both physical and mental health difficulties, more frequently than those
without depression (Ciechanowski, Katon, & Russo, 2000; Kaholokula, Haynes,
Grandinetti, & Chang, 2003). This particular outcome may be related to poor control of
diabetes, such that depressed mood may result in less motivation to properly manage
diabetes or feelings of hopelessness about one’s ability to manage diabetes. In addition,
Zhang, Norris, Gregg, Cheng, Beckles, and Kahn (2005) found that severe depressive
symptoms significantly elevated the risk for mortality among U.S. adults with diabetes.
One of the more commonly studied diabetes-related outcomes is glycemic
control. Glycemic control is fundamental to the management of diabetes (American
Diabetes Association, 2005). The most common techniques for effective assessment of
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glycemic control are self-monitoring of blood glucose by diabetes patients and health
care providers performing A1C tests every two to three months. Lower A1C levels have
been associated with lower risk of diabetes-related health complications, including heart
attacks, cardiovascular-related deaths, and reduction of microvascular and neuropathic
complications (American Diabetes Association, 2005).
Research examining the relationship between depression and glycemic control has
provided mixed results. The results of a meta-analytic investigation of 24 studies
measuring the association between depression and glycemic control, as indicated by an
assessment of total glyco-hemoglobin (GHb), suggested that depression was associated
with poor glycemic control (hyperglycemia) among patients with type 1 and type 2
diabetes, although the direction of the relationship was not specified (Lustman, Anderson,
Freedland, de Groot, Carney, and Clouse, 2000). The results of several studies have
shown a significant relationship between depression and A1C levels in individuals with
type 1 diabetes, suggesting that the more severe the depression, the worse the glycemic
control (Ciechanowski, Katon, Russo, & Hirsch, 2003; Lustman, Clouse, Ciechanowski,
Hirsch, & Freedland, 2005; Pouwer & Snoek, 2001). However, the results of other
studies have shown no evidence of a relationship between depression and A1C levels in
persons with type 2 diabetes (Ciechanowski et al., 2000; Ciechanowski et al., 2003;
Kaholokula et al., 2003; Lee, Chapa, Kao, Jones, Kapustin, et al. 2009). Such a variety of
findings could be due to most of these studies having a cross-sectional vs. longitudinal
designs, as well as differences in populations used and covariates examined.
Recent research suggests that racial and ethnic minorities, particularly members
of non-White Hispanic and Black American populations, are less likely than members of
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non-Hispanic White populations to achieve glycemic control (Fan, Koro, Fedder, &
Bowlin, 2006; Saydah, Cowie, Eberhardt, DeRekeneire, & Narayan, 2007; Suh,, Choi,
Plauschinat, Kwon, & Baron, 2010). A number of factors have been investigated in order
to better understand and explain this health disparity, including racial and ethnic
differences in the access to health care and prescription drug coverage, differences in
preventative care practices, receipt of less optimal care from providers, and biological
and socioeconomic factors (Kirk, D’Agostino, Bell, Passmore, Bonds, et al., 2006).
Racial and ethnic differences in depression are another factor potentially
maintaining the racial and ethnic differences in glycemic control. The relationship
between depression and glycemic control among racial and ethnic minority populations
has been investigated in a few studies, with most studies focusing on Black American
populations. Gary, Crum, Cooper-Patrick, Ford, and Brancati (2000) found that among
Black Americans with type 2 diabetes, depressive symptoms were marginally associated
with higher A1C levels, but was significantly associated with higher levels of total
cholesterol and triglyceride. In an ethnically diverse sample of elderly diabetes patients,
another study found a weak relationship between depression and A1C, but also found that
depression did not predict change in glycemic control (Trief, Moin, Izquierdo, Teresi,
Eimicke, et al., 2006). Recently, Wagner, Abbott, Heapy, and Yong (2009) found that
higher depressive symptoms were associated with higher A1C, more long-term diabetes
complications, and more diabetes medications among a sample of Black Americans. The
findings of these studies suggest a relationship between depression and poor diabetes
control among Black Americans. However, it appears that more studies exploring
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multiple racial and ethnic minority populations are needed to better understand possible
racial and ethnic differences.
Generally, depression appears to be related to increased diabetes complications,
poorer quality of life, and increased mortality risk among patients with diabetes.
Although the results are mixed, depression also appears to have some relationship to
glycemic control among patients with diabetes, particularly among Black Americans.
Diabetes, Depression, and Sexual Dysfunction
Sexual dysfunction is another diabetes-related complication that can potentially
be associated with both depression and diabetes. Both male and female patients with
diabetes report difficulties with sexual dysfunction. Estimates of the prevalence of sexual
dysfunction in women with diabetes range from 18 to 42%, while prevalence estimates of
erectile dysfunction in men with diabetes ranges from 20 to 75% (National Diabetes
Information Clearinghouse, 2008).
Results of a recent review of studies investigating sexual dysfunction in women
with diabetes revealed that type 2 diabetes seemed to have a greater impact on women’s
sexuality than type 1 diabetes, which the authors hypothesized may be related to age,
menopausal status, co-morbid factors, or social and psychological factors (Giraldi and
Kristensen, 2010). Sexual problems in women with diabetes mostly include lack of
sexual desire, sexual dissatisfaction, orgasmic disorder, arousal disorder and poor
lubrication (Bultirini, Carosa, Colpi, Poccia, Iannarelli, et al, 2004). Some research
findings suggest that neuropathy, vascular impairment, and psychological complaints are
possible risk factors of female sexual dysfunction in diabetic women (Amaral, Oliveira,
& Ramalho-Santos, 2008), while other findings suggest that the incidence of sexual
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dysfunction in women with diabetes may be less related to physical diabetes
complications and more related to psychological factors, including quality of the partner
relationship and coexisting depression (Enzlin, Mathieu, Van Den Bruel,
Vanderschueren, & Demyttenaere, 2003; Giraldi & Kristensen, 2010).
Men who have diabetes are two to three times more likely to have erectile
dysfunction than men who do not have diabetes, and men with diabetes may experience
erectile dysfunction as much as 10 to 15 years earlier than men without diabetes (NDIC,
2008). Research findings suggest that diabetes causes damage to nerves throughout the
body including the penis, making neuropathy a major risk factor for erectile dysfunction
(Agostini, Rossi, & Pajalich, 2006; Zdravko, Kamenov, Tsanka, & Yankova, 2007).
While some research findings suggest that significant risk factors for sexual dysfunction
in men, but not women, included BMI, duration of diabetes, and diabetic complications
(Enzlin, 2003), other research findings indicated no major gender differences between
sexual dysfunction and age, diabetes status, duration of diabetes and hypertension (ZiaeiRad, Vahdaninia, & Montazeri, 2010).
There is very little research estimating the prevalence of sexual dysfunction
among members of racial and ethnic minority groups in the general population and
reported rates of sexual dysfunction for men appear to be inconsistent. Laumann, Paik,
and Rosen (1999) found racial and ethnic differences in the prevalence of sexual
problems among a sample of 1,410 men and 1,749 women, namely that Black Americans
appeared more likely than White Americans and non-White Hispanics to have sexual
problems, and non-White Hispanics appeared less likely to have sexual problems. These
results were particularly significant among women, with specific problem areas including
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lack of desire for sex, arousal difficulties, inability to achieve climax or ejaculation,
anxiety about sexual performance, climaxing or ejaculating too rapidly, physical pain
during intercourse, and not finding sex pleasurable (Laumann et al., 1999). However,
Saigal, Wessells, Pace, Schonlau, and Wilt (2006) found among a sample of 3566 men,
that non-White Hispanic men, younger than 50 years of age, had more than twice the
prevalence of erectile dysfunction compared with similar non-Hispanic Black and nonHispanic White men.
Another study examining racial and ethnic differences in sexual dysfunction
among middle-aged women found significant group differences for sexual arousal, pain
during intercourse, desire, and frequency of sexual intercourse. Specifically, Black
American women reported higher frequency of sexual intercourse than White American
women; non-White Hispanic women reported lower physical pleasure and arousal; and
Chinese women reported more pain and less desire and arousal than the white women, as
did the Japanese women (Avis, Zhao, Johannes, Ory, Brockwell, & Greendale, 2005).
Unfortunately, no studies were found that estimated the prevalence of sexual
dysfunction among members of racial and ethnic minority groups with diabetes, although
some studies estimated the prevalence of erectile dysfunction among members of racial
and ethnic minority groups with other chronic diseases, including prostate cancer and
heart failure (Siegel, Moul, Spevak, Alvord, & Costabile, 2001; Hebert, Lopez,
Castellanos, Palacio, Tamariz, & Arcement, 2008). Given that diabetes is the leading
contributor to erectile dysfunction and is also significantly related to sexual dysfunction
in women, knowledge of racial and ethnic differences in prevalence rates could enhance
understanding and possibly treatment of sexual dysfunction among those with diabetes.
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Similar to the literature on the relationship between depression and glycemic
control, study results regarding a relationship between sexual dysfunction and glycemic
control are mixed. Only a few studies have examined the relationship between sexual
dysfunction and glycemic control. Some studies have found no relationship between
sexual dysfunction and levels of A1C among both genders (Shiri, Ansari, & Hassani,
2006; Ziaei-Rad et al., 2010). Other studies have identified glycemic control as an
independent predictor of sexual dysfunction in men (Khatib, Jarrah, Shegem, Bateiha,
Abu-Ali, & Ajlouni, 2006), while others have found no relationship between glycemic
control and sexual dysfunction in women (see Giraldi & Kristensen, 2010). Overall, it
appears that further research is needed to better understand the possible association
between sexual dysfunction and glycemic control, particularly among men.
Sexual dysfunction, specifically loss of interest in sexual activity, is a common
symptom of depression, and the occurrence of sexual dysfunction appears to be
consistently higher in patients with depression than in the general population (Kennedy &
Razvi, 2009). Kennedy, Dickens, Eisfeld, and Bagby (1999) found that among 55 males
and 79 females diagnosed with major depression, some of the frequently reported sexual
problems in untreated patients with depression included reduction in sexual desire
(approximately 40% of men and 50% of women), difficulties with erection/ejaculation
(22% of men), or difficulties with orgasm (15% of women). Also, it seems that the
relationship between sexual dysfunction and depression could be bidirectional, in that the
presence of either one of these conditions may trigger or exacerbate the other (Kennedy
& Razvi, 2009).
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Patients with diabetes and depression may be particularly vulnerable to the effects
of sexual dysfunction. However, very few studies have examined the relationship
between depression and sexual dysfunction among patients with diabetes. Results of a
recent review of the literature on sexual dysfunction and women with diabetes revealed
that depression appeared to be a significant risk factor for female sexual dysfunction
(Giraldi & Kristensen, 2010). Among men with diabetes, the risk of erectile dysfunction
was found to be higher in those with depression compared to those without depression
(Shiri et al., 2006); no studies examining racial and ethnic differences were found. Given
the potential impact depression has on patient management of their diabetes, and the
increased physical and psychological impact that sexual dysfunction may have on patient
management of their diabetes, more information is needed regarding the impact of
depression and sexual dysfunction on diabetes management, particularly on glycemic
control; racial and ethnic differences also need to be further explored.
Summary
Diabetes prevalence rates are on the rise, particularly among members of racial
and ethnic minority groups. Patients with diabetes are more vulnerable to developing
depressive symptoms when compared to those without diabetes, with some racial and
ethnic differences in treatment and rates of diagnosis. Depression appears to influence the
relationship to diabetes-related health complications, including glycemic control. Based
on published studies, there appears to be no racial and ethnic differences in depression
prevalence estimates among diabetes patients; however, racial and ethnic minorities are
less likely to achieve glycemic control, and may be at greater risk for diabetes related
health issues.
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One of the many health complications related to diabetes is sexual dysfunction,
with diabetes patients being more vulnerable to sexual dysfunction than those without
diabetes. The results of a possible relationship between sexual dysfunction and glycemic
control are inconsistent, and while there is some research examining racial and ethnic
differences in the general population, the findings are also inconsistent and there is very
little research examining racial and ethnic differences in the prevalence of sexual
dysfunction among individuals with diabetes. Despite the risk of depression among those
with diabetes and the potential psychological impact of sexual dysfunction, the
relationship between, and the impact of, depression and sexual dysfunction has received
very little attention in the diabetes research literature.
The Current Study
This study was designed to address gaps in the diabetes literature by contributing
more information regarding racial and ethnic differences. Specifically, this study was
designed to test racial and ethnic differences in the prevalence of depression, and, to the
best of this author's knowledge, will be one of the first investigations designed to
examine racial and ethnic differences in sexual dysfunction among men with diabetes.
The purpose of this study is to explore the potential impact of depression and sexual
dysfunction on glycemic control among individuals with diabetes, namely if individuals
with diabetes diagnosed with depression and/or sexual dysfunction (i.e., depression only,
sexual dysfunction only, or comorbid depression/sexual dysfunction) have more
difficulties with glycemic control compared to individuals with diabetes who have neither
disorder. This study was designed to explore the possibility of a longitudinal impact of
these disorders on glycemic control, as well as possible racial and ethnic differences.
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This study is designed to explore these questions using a sample of veterans.
Diabetes is highly prevalent among veterans. Of 877,775 veterans surveyed by Miller,
Safford, and Pogach (2004), the prevalence of diabetes among veterans was 19.6% in
2000, and the annual incidence of diabetes in veterans is approximately 2% per year.
Diabetes is the third most common diagnosis in the VA system, affecting 25% of 22,645
VA patients surveyed by Reiber, Au, McDonell, and Fihn (2004).
Also, the prevalence of depression among veterans with diabetes and the possible
impact of depression on glycemic control among members of this population have been
examined in few studies. According to the Veterans Health Administration (VHA)
External Peer Review Program (EPRP), 85% of 21,489 veterans have received annual
depression screenings since fiscal year 2004 (Office of Quality Performance, 2006), and
on average, almost 9% of veterans screen positive for depression (Desai, Rosenheck, &
Craig, 2006). In regards to glycemic control, one study using a cohort of veterans with
type 2 diabetes to investigate the longitudinal effects of depression on glycemic control
found a significant relationship between depression and glycemic control as measured by
A1C, and that depression appeared to be associated with persistently higher A1C levels
over time (Richardson, Egede, Mueller, Echols, & Gebregziabher, 2008). Also, similar to
the non-veteran population, veterans who are members of racial and ethnic minority
groups have been found to have poorer glycemic control (higher A1C levels) when
compared to White American veterans (Egede, Mueller, Echols, & Gebregziabher, 2010).
Given these findings it may be beneficial to start to explore this study’s research
questions using a sample of veterans. While this research could improve the overall
health and management of diabetes among veterans, particularly racial and ethnic
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minority veterans, it could also inform possible future investigations of these issues in the
general diabetes population. The specific research questions and hypotheses are as
follows:


Question 1: Are there racial and ethnic differences in the prevalence rates of
depression among veterans with diabetes?
o Hypothesis 1: Consistent with existing literature, there will be racial
and ethnic differences in rates of depression among veterans with
diabetes, with White American veterans having higher rates than Black
American veterans.



Question 2: Are there racial and ethnic differences in rates of sexual
dysfunction among veterans with diabetes?
o Hypothesis 2: There will be racial and ethnic differences in rates of
sexual dysfunction, with racial and ethnic minority veterans with
diabetes having higher rates than White American veterans.



Question 3: Are there longitudinal racial and ethnic differences in A1C levels
(glycemic control) among veterans with diabetes?
Hypothesis 3: Consistent with existing literature, there will be longitudinal
racial and ethnic differences in A1C levels, with racial and ethnic minority
veterans having higher A1C levels compared to White American veterans
over time.



Question 4: Do veterans with diabetes experiencing depression and/or sexual
dysfunction have higher A1C values (poorer glycemic control) over time
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compared to diabetic veterans with neither depression nor sexual dysfunction?
Are there racial and ethnic differences in A1C values?
o Hypothesis 4: Veterans with diabetes experiencing depression and/or
sexual dysfunction are expected to have higher A1C levels over time
compared to veterans with diabetes with neither disorder. Racial and
ethnic differences are also expected, with members of racial and ethnic
minority groups having higher A1C levels within each diagnostic
group.
Overall, this study will provide more information about the impact of depression
and sexual dysfunction on veterans with diabetes and their abilities to manage their
diabetes, while highlighting the possibility of racial and ethnic differences. This research
will further inform future investigations of these issues in the general diabetes population.
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CHAPTER 2
METHODS
Study Data
The data for this study were extracted from the Veteran’s Affairs (VA)
Informatics and Computing Infrastructure (VINCI), which is partnered with the
Corporate Data Warehouse (CDW) and provides VA researchers access to integrated
national datasets and tools for analysis in a secure, high-performance computing
environment. The data are accessible to authorized users only, who log onto VINCI via a
virtual private network connection (VPN) or through a computer on the VA intranet
through a Secure Gateway. VINCI stores the requested data on a Standard Workspace.
By Office of Research and Development (ORD) policy, VINCI is not authorized to allow
the transfer of any patient-level data out of its secure environment without special
permission. To ensure data security, VINCI created a File Transfer Utility to facilitate all
data transfers including the transfer of tables and graphics generated as part of routine
analysis.
The data for this study entailed records of inpatient and outpatient visits to
VAMC’s throughout the nation, including primary care visits and specialty care visits.
The clinical data obtained for this study included: International Classification of
Diseases, Ninth Edition (ICD-9) diagnostic codes for type 2 diabetes, depression and
sexual dysfunction; laboratory data with HbA1c results; ICD-9 diagnostic codes for the
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possible comorbid diagnoses of hypertension, coronary heart disease, and stroke; and
demographic data, including age, race, gender, marital status, and state of residence.
Study Population
A national cohort of 105,411 veterans with diabetes who had received a diagnosis
of depression and/or sexual dysfunction between June 2007 and June 2012 were
identified. Racial and ethnic groups included were then as non-Hispanic White (NHW),
non-Hispanic Black (NHB), and Other (Asian, Native Hawaiian/Pacific Islander, and
Native American/Alaskan Native). There were several collection methods for race
included in the raw data, including “observer”, “proxy”, “unknown”, or no collection
method specified. Only veterans with a “self-identification” method associated with race
were included, as it was deemed to be the most reliable source of race information. It
should be noted that although non-White Hispanic populations were discussed in the
Introduction, non-White Hispanic veterans were not clearly identified in this study’s
sample, likely due to a coding issue in the database; this issue will be discussed further in
the Discussion. Veterans diagnosed with schizophrenia and/or bipolar disorders were
excluded from the analyses to be consistent with the overall purpose of the investigation.
Design and Procedures
Measures
Diagnoses of depression and sexual dysfunction were determined based on ICD-9
codes associated with billable encounters found in patient medical records. In other
words, diagnoses were determined based on a veteran having at least one clinical
encounter during which depression or sexual dysfunction was identified as a primary or
secondary issue noted during the appointment. Veterans were then classified into four

18

diagnostic categories based on the ICD-9 codes. Veterans with at least one ICD-9 code
for depression (296.2, 296.3, 296.9, 300.4, 311) were included in the depression only
group; veterans with at least one ICD-9 code for sexual dysfunction (320, 799.81, V41.7)
were included in the sexual dysfunction only group; veterans with at least one ICD-9
code for both depression and sexual dysfunction were included in the comorbid
depression/sexual dysfunction group; and veterans with no ICD-9 code for either
depression or sexual dysfunction were included in the no diagnosis group.
For this study, glycemic control was defined by lab test results for hemoglobin
A1C. A1C test results show a patient’s average blood sugar level over time. The result is
reported as a percentage. The American Diabetes Association (ADA) recommends that
diabetes patients keep their A1C levels less than 7%, which is considered normal
glycemic control; an A1C level greater than 8% is considered poor glycemic control.
(ADA, 2005). Results of lab test data for A1C in a given 3-month time interval was
extracted from patient medical records. The 3-month interval was chosen because A1C
levels are generally measured every three months, which is the approximate lifespan of
the red blood cells that store blood glucose information. For patients with two or more
A1C values in a given 3- month time interval, the most recent A1C value for that interval
was used as it would include the most recent blood glucose information stored in the red
blood cells.
Data Analytic Strategy.
Several analyses were conducted to obtain descriptive statistics and to test the
study hypotheses. Descriptive information was obtained by comparing demographic and
clinical variables across the four diagnostic groups (Table 2.1). Descriptive statistics

19

revealed that females and members of the “Other” racial and ethnic group comprised only
small percentages of the total sample at 7% and 5%, respectively. These groups were
removed from further study analyses, due to the difficulty of making meaningful
statistical inferences about these populations given the small sample sizes and the
heterogeneity of the ‘Other’ racial and ethnic group.
The age range for the participants in the sample was large (i.e., 23-years-old to
103-years-old), which highlights the heterogeneity of the sample. Given this study’s
accelerated longitudinal design, it is standard procedure to rescale the ‘Time’ variable to
age, which models participants to enter and leave the study at different times as opposed
to modeling them all as covering the same time in each participant’s lives. To rescale
time to age, a person–period dataset was created for each patient to cover 3-month
intervals from June 2007 to June 2012 to correspond with patient A1C results data. Each
3-month interval was then assigned a corresponding number to create the time variable
‘Time-Period’ (i.e., June 2007 = Time-Period 0). The ‘Time-Period’ values and the
minimum age for the sample (23-years-old) were then used to create a new time variable
accounting for age, ‘Time’, using the following formula: Time= ((Patient Age – 23) +
(.25*Time-Period))/Constant. The normality of the distribution of the newly created time
variable was assessed and while the distribution was found to be normal, the tail ends of
the distribution were long. Cases below the 25th and above the 75th percentiles were
dropped to remove the extreme cases from the study, leaving 52,039 patients in the final
study sample.
To examine racial and ethnic differences in the rates of depression and sexual
dysfunction (Hypotheses 1 and 2), chi-square analyses of depression and sexual
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dysfunction diagnoses by racial and ethnic group were conducted. General linear mixed
models were used to test hypotheses 3 and 4. To address hypothesis 3, a general linear
model was conducted to compare unadjusted mean A1C values across all time points for
each of the racial and ethnic groups. Next, a linear mixed model approach was used to
model the relationship between A1C levels as a continuous variable and race and
ethnicity over time. The model included A1C as the dependent variable (y), and race (x)
and time (t) as primary variables of interest, and the interaction between x and t (y on x, t,
and x*t).
Similar procedures were used to examine A1C levels over time among veterans
with diabetes in the four diagnostic groups (Hypothesis 4). Again, a general linear model
approach was used to compare unadjusted mean A1C values across all time points, this
time for each of the depressed/sexual dysfunction diagnostic groups, and a general linear
mixed model approach was used to examine changes over time in A1C levels among the
different depressed/sexual dysfunction diagnostic groups, as well as to explore possible
racial and ethnic differences in A1C levels within diagnostic groups. Model building
occurred in a hierarchical fashion. The first linear model contained A1C as a dependent
variable (y), and diagnostic group (x) and time (t) as the primary fixed effects of interest.
Thus, the first model included x, t, and the interaction between x and t (y on x, t, and x*t).
To examine possible racial and ethnic differences within diagnostic groups, a second
linear fitted with the diagnostic group as a primary fixed effect of interest and race as a
further adjustment variable (y on x, t, and race), along with the interaction term between
race and the diagnostic group (y on x, t, race, and x*race). A final model was fitted to
examine the impact of other covariates on racial and ethnic differences within diagnostic

21

groups. All models contained a person-level random effect to account for correlation of
A1C values within individuals. Also, least square means were obtained from all models
to compare adjusted mean A1C values for the different diagnostic groups. All statistical
tests were conducted in SAS, using a two-tailed α=0.05 level of significance.
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Table 2.1- Original sample demographic and clinical characteristics

N
(%)
Mean A1C values
(S.D.)
Mean age in years
(S.D.)
Sex (%)
Male
Female
Race/ethnicity (%)
Black
White
Other
Marital Status (%)
Never Married
Married
Separated
Divorced
Widowed
Hypertension (%)
Heart Disease (%)
Stroke (%)

Depression

Sexual
Dysfunction

Neither
Diagnosis

All

1,744
(2%)
7.33
(1.46)
67.3
(8.78)

Depression/
Sex
Dysfunction
20,323
(19%)
7.44
(1.65)
65.4
(8.49)

76,048
(72%)
7.23
(1.51)
66.6
(11.17)

7,296
(7%)
7.25
(1.56)
69.8
(11.16)

105,411

91.5
8.5

99.9
0.11

99.3
0.68

95.5
4.55

93.4
6.6

13.7
81.5
4.7

25.3
69.1
5.3

22.8
72.0
5.2

15.0
79.6
5.4

15.9
79.3
4.9

8.3
54.0
3.4
25.3
9.1
91.0
48.5
23.5

6.4
55.0
3.7
28.7
6.2
93.6
50.1
23.2

6.1
57.2
4.4
26.4
5.8
93.8
48.2
23.2

8.4
51.7
3.2
26.2
10.5
90.0
52.9
25.6

7.9
54.5
3.6
25.6
8.5
91.5
48.8
23.6

23

7.31
(1.53)
66.5
(9.90)

CHAPTER 3
RESULTS
This study included data from a national sample of 52,039 veterans. The mean
age was 66-years-old (M = 66.0, SD = 2.80), with ages ranging from 60 to 70-years-old,
and 59% of the sample self-identified as married. Eighty-six percent (86%) were White
American and 15% were Black American. Sixty-eight percent (68%) had been diagnosed
with depression only, 2% with sexual dysfunction only, 24% with comorbid
depression/sexual dysfunction, and 6% had neither diagnosis. See Table 3.1 for additional
demographic information for the sample.
Hypotheses 1 & 2: Depression and Sexual Dysfunction Prevalence
Chi-square results revealed racial and ethnic differences in the prevalence of
depression among veterans with diabetes [2 (2, N = 52,039) = 30.64, p < .0001], with
White American veterans having higher rates of depression (91%) than Black American
veterans (90%). However, the effect size for this analysis was small (phi = .02), which
suggest that despite the statistical significance of the Chi-square finding, the overall
differences in depression rates between White American veterans and Black American
veterans was not large. Chi-square results also revealed significant racial and ethnic
differences in the prevalence of sexual dysfunction [2 (2, N = 52,039) = 721.06, p <
.0001], with Black American veterans having higher rates of sexual dysfunction (38%)
than White American veterans (24%). The effect size for this analysis was also small (phi
= .12), which suggests that despite the statistical significance of the Chi-square finding,
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the overall differences in sexual dysfunction rates between Black American veterans and
White American veterans was also not large.
Hypothesis 3: Racial and Ethnic Differences in A1C Levels over Time
Table 3.2 shows the results for examining racial and ethnic differences in changes
in A1C levels over time. Results indicate there was a significant race-by-time interaction
(β= -.30, t (51,997) = -5.77, p <.0001), indicating a significant difference in the changes
of mean A1C levels over time between White American and Black American veterans.
Figure 3.1 depicts these mean changes in A1C levels over time, demonstrating a decrease
in mean A1C levels for Black American veterans as age increases, whereas mean A1C
levels for White Americans increased in relation to an increase in age. Specifically, the
mean A1C level for Black American veterans decreased from about 7.3% at age 60 to
about 7.2% by age 74. Conversely, the mean A1C level for White American veterans
increased from about 7.1% at age 60 to about 7.2% by age 74.
Hypothesis 4: Diagnostic Group Differences in A1C Levels over Time
Table 3.3 shows the results of Model 1 with A1C level as the dependent variable
and diagnostic group as independent variable (adjusted for time). Results indicate a
significant difference in A1C levels between veterans with a diagnosis of depression
and/or sexual dysfunction and those without either diagnosis. Specifically, veterans with
sexual dysfunction only had significantly higher A1C levels when compared to veterans
with no diagnoses of depression or sexual dysfunction (β= .13, t (51,996) = 2.79, p = .01).
Least square mean results for this model indicate a statistically significant mean
difference in A1C levels between veterans with sexual dysfunction and those with no
diagnosis, specifically, A1C levels for veterans with sexual dysfunction were 0.08

25

percentage points higher than A1C levels for veterans with no diagnosis (95% CI [0.03,
0.12], p = 0.001). Additionally, there were no significant diagnostic group-by-time
interactions, indicating that there were no significant differences in the changes of mean
A1C values as veterans within each diagnostic group increased in age (Figure 3.2).
A second model was run to examine possible racial and ethnic differences in A1C
levels within each diagnostic group over time. Table 3.4 shows the results of Model 2
with A1C as the dependent variable and race and diagnostic group as independent
variables (adjusted for time). Results revealed a significant race*group*time interaction
for veterans in the depression group (β= -0.42, t (51,996) = -2.02, p = .04), indicating a
significant difference in the changes of mean A1C levels over time between Black
American veterans and White American veterans diagnosed with depression. Figure 3.3
presents these mean changes in A1C levels over time, demonstrating a decrease in mean
A1C levels for Black American veterans diagnosed with depression as age increases,
whereas mean A1C levels for White American veterans with depression increased in
relation to an increase in age. Specifically, the mean A1C level for Black American
veterans with depression decreased from about 7.3% at age 60 to about 7.2% by age 74.
Conversely, the mean A1C level for White American veterans with depression increased
from about 7.1% at age 60 to about 7.2% by age 74.
Building on Model 2, a third model was run to examine the impact of additional
disease co-morbidities on possible racial and ethnic differences in A1C levels within each
diagnostic group over time. Table 3.5 shows the results of Model 3 with A1C as the
dependent variable, race and diagnostic group as independent variables (adjusted for
time), and hypertension, coronary heart disease, and history of stroke as disease
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covariates. Results revealed that the significant race*depression*time interaction found in
Model 2 was maintained in this model (β= -.43, t (50,564) = -2.05, p = .04). Figure 3.4
presents these mean changes in A1C levels over time, demonstrating the same trend
found in Model 2: a decrease in mean A1C levels for Black American veterans diagnosed
with depression from about 7.3% at age 60 to about 7.2% by age 74 and an increase in
mean A1C levels for White American veterans with depression from about 7.1% at age
60 to about 7.2% by age 74.
Post-hoc Analyses: Assessing for Curvilinear Trajectories
Upon closer analysis of the simple slopes for the linear model analyses, it seemed
important to assess for possible curvilinear trajectories in the data. The linear modeling
results suggested that A1C levels for veterans with diabetes gradually increased for White
American veterans or decreased for Black American veterans as they get older. However,
it’s possible that the change in A1C over time is better understood as a curvilinear
relationship, such that A1C levels should reach and optimal level (i.e., less than 7% for
individuals with diabetes), and then stabilize rather than continue to increase or decrease
as they get older. A curvilinear model may also provide more accurate information
regarding the rate of change in A1C levels over time. For example, an individual newly
diagnosed with diabetes could have a more rapid improvement in A1C levels initially as
they take more deliberate steps to maintain healthy blood sugar levels, but then the rate of
change slows as A1C levels begin to stabilize, assuming the individual’s blood sugar
levels remain under control.
Given the possible real-life trajectories for change in A1C levels, new analyses
were conducted to fit the proposed longitudinal hypotheses (hypotheses 3 and 4) with
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quadratic modeling. Specifically, while the previously tested linear model for racial and
ethnic differences in A1C levels over time included A1C as the dependent variable (y),
and race (x) and time (t) as primary variables of interest, and the interaction between x
and t (y on x, t, and x*t), the non-linear model included A1C as the dependent variable
(y), and race (x), time (t), and the quadratic term for time (t2) as primary variables of
interest, and the interactions between x, t, and t2 (y on race, t, race*t, t*t2, and race*t2).
The same modeling procedure was used for exploring a quadratic relationship for
changes in A1C levels over time for veterans with depression and/or sexual dysfunction
(y on x, t, x*t, t*t2, and x*t2), and possible racial and ethnic differences in A1C levels
over time (y on race, x, t, race*x, race*t, x*t, race*t2, x*t2, t*t2, race*x*t, and race*x*t2).
All models included a person level random effect to account for within-individual
correlations of A1C values. Because t and t2 are highly correlated, contrast tests for each
two, three, and four-way interaction with the t or t2 term were conducted as well as a
contrast test for the goodness of fit for the quadratic model.
Results for Curvilinear Modeling
Racial and ethnic differences in A1C levels over time.
Table 3.6 shows the results for examining a curvilinear relationship for racial and
ethnic differences in changes in A1C levels over time. Results indicate that there was a
significant contrast test for race*t and race*t2, indicating that race had a significant effect
on A1C levels over time (p < 0.001). The contrast testing for improvement in goodness of
fit of the quadratic modeling was also significant (p < 0.001), indicating the quadratic
modeling of this analysis was a better fit than the linear modeling. Figure 3.5 depicts
mean changes in A1C levels over time, demonstrating that Black American veterans
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appeared to start with higher mean A1C levels that seemed to peak at a younger age
before they began to gradually decrease. Mean A1C levels for White American veterans
started lower and peaked and plateau at a later age compared to Black American veterans.
Specifically, analyses revealed mean A1C levels for Black American veterans was 7.28%
at age 60, peaked at 7.30% around age 62, and then decreased to 7.18% by age 74. The
mean A1C level for White American veterans was 7.02% at age 60, peaked at 7.20%
around age 68, and still remained at this level by age 74.
Diagnostic group differences in A1C levels over time
Table 3.7 shows the results for examining a curvilinear relationship for diagnostic
group differences in changes in A1C levels over time (Model 1.2). Results revealed
significant contrasts for sex dysfunction*time and sex dysfunction*time2 (p = .0003) as
well as for depression*sex dysfunction*time and depression*sex dysfunction*time2 (p =
.001). The significant contrasts indicate that veterans with sexual dysfunction and
veterans with both depression/sexual dysfunction had significantly different changes in
mean A1C levels over time compared to veterans with no diagnosis. The contrast testing
for improvement in goodness of fit of the quadratic modeling was also significant (p <
0.001), indicating the quadratic modeling of this analysis was a better fit than the linear
modeling. Figure 3.6 depicts mean changes in A1C levels over time. Specifically, A1C
levels for veterans with only sexual dysfunction appeared to start higher than those for
veterans with no diagnosis, but they also peaked at an earlier age and decreased more
rapidly than A1C levels for veterans with no diagnosis. Additionally, A1C levels for
veterans with both depression/sexual dysfunction appeared to start at levels similar to the
no diagnosis group and plateaued around the same age, but at a higher A1C levels than
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the no diagnosis group. Specifically, the mean A1C levels for veterans with only sexual
dysfunction was about 7.20% at age 60, peaked at 7.35% around age 62, and then
decreased to about 7.04% by age 74. The mean A1C level for veterans with both
depression/sexual dysfunction was about 7.06% at age 60, peaked at 7.25% around age
68, and still remained at this level by age 74. The mean A1C level for veterans with no
diagnosis was about 7.06% at age 60, peaked at 7.20% around age 68, and still remained
at this level by age 74.
Table 3.8 shows the results of the model examining a possible curvilinear
relationship for racial and ethnic differences in A1C levels within each diagnostic group
over time (Model 2.2). Results, revealed that the significant contrasts found in Model 1.2
were maintained, sex dysfunction*time and sex dysfunction*t2 (p = .01) and
depression*sex dysfunction*t and depression*sex dysfunction*t2 (p = .02). However,
there were no significant contrasts for any of the race*group categories over time,
suggesting that there are no racial and ethnic differences in the patterns of change in A1C
among veterans diagnosed with depression and/or sexual dysfunction. There was also no
significant contrast for testing improvement in goodness of fit of the quadratic modeling
(p = .11), indicating that the quadratic modeling was not a better fit for this analysis when
compared to the linear modeling.
Table 3.9 shows the curvilinear modeling results for racial and ethnic differences
in A1C levels among veterans with depression and/or sexual dysfunction after adjusting
for additional covariates of hypertension, coronary heart disease, and history of a stroke
(Model 3.2). Results reflect significant main effects for hypertension and coronary heart
disease. However, the addition of covariates did not significantly impact Model 2.2, as
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the significant contrasts for sexual dysfunction (p = .01) and comorbid depression/sexual
dysfunction (p = .02) were sustained in this model. Again, here was also no significant
contrast for the goodness of fit of the quadratic modeling (p = .07), indicating that the
quadratic modeling was not a better fit for this analysis when compared to the linear
modeling.
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Table 3.1- Final sample demographic and clinical characteristics

N
Mean A1C values
(S.D.)
Mean age in years
(S.D.)
Race/ethnicity (%)
Black
White
Marital Status (%)
Never Married
Married
Separated
Divorced
Widowed
Hypertension (%)
Heart Disease (%)
Stroke (%)

Depression

Sexual
Dysfunction

35,328
(68%)
7.20 (1.48)

1,054 (2%)
7.43 (1.54)

Depression/
Sex
Dysfunction
12,350
(24%)
7.35 (1.49)

66.0 (2.81)

66.1 (2.75)

65.9 (2.73)

66.2 (2.86)

12.3
87.7

25.6
74.4

21.9
78.1

15.5
84.5

15.1
85.9

6.9
58.7
3.1
26.5
4.9
92.6
49.7
22.2

5.5
57.6
2.8
29.6
4.6
94.5
50.3
22.8

5.0
59.9
3.9
26.5
4.6
94.8
50.1
23.0

8.1
52.8
3.6
30.7
4.8
90.1
53.0
22.2

6.5
58.6
3.3
26.8
4.8
93.0
50.0
22.4
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Neither
Diagnosis

All

3,307 (6%)

52,039

7.27 (1.48)

7.31
(2.81)
66.0
(2.80)

Table 3.2- Fixed effect estimates for changes in A1C values across racial groups over
time.

Intercept (ref. = NHW)
Non-Hispanic Black
Time
Non-Hispanic Black*Time
*p < .001

Beta coefficient
estimate
7.14
0.11
0.22
-0.30

Standard Error

P-value

0.01
0.01
0.02
0.05

<.0001***
<.0001***
<.0001***
<.0001***

Figure 3.1- Mean changes in A1C levels over time for Black American and White
American veterans.
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Table 3.3- Fixed effect estimates for changes in A1C values across diagnostic groups
over time (Model 1).

Intercept (ref. = No diagnosis)
Depression
Sexual Dysfunction
Depression/Sex Dysfunction
Time
Depression*Time
Sexual Dysfunction*Time
Depress/Sex Dys*Time
*p < .01

Beta coefficient
estimate
7.17
-0.02
0.13
0.07
0.09
0.10
-0.28
0.29

Standard
Error
0.02
0.02
0.05
0.05
0.08
0.08
0.15
0.15

P value
<.0001***
0.37
0.01*
0.13
0.25
0.23
0.06
0.06

Figure 3.2- Mean changes in A1C levels over time for veterans with depression and/or
sexual dysfunction.
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Table 3.4- Fixed effect estimates for racial differences in A1C values within diagnostic
groups (Model 2).

Intercept (ref.= No diagnosis,
White)
Non Hispanic Black
Depression
Sex Dysfunction
Depression/Sex Dysfunction
Time
NHB*Depression
NHB*Sex Dysfunction
NHB*Depress/Sex Dys
Black*Time
Depression*Time
Sex Dysfunction*Time
Depress/Sex Dys* Time
Depression*Black*Time
Sex Dysfunction*Black*Time
Depress/Sex Dys* Black*Time
**p < .01, *p < .05,

Beta coefficient
estimate
7.14

Standard
Error
0.02

<.0001****

0.23
-0.003
0.09
-0.06
-0.01
-0.14
-0.04
0.06
0.16
0.12
-0.39
0.39
-0.42
0.02
-0.05

0.06
0.03
0.05
0.05
0.08
0.06
0.11
0.11
0.20
0.08
0.16
0.16
0.21
0.34
0.36

0.01**
0.89
0.08
0.29
0.93
0.03*
0.73
0.58
0.43
0.14
0.01*
0.02*
0.04*
0.94
0.88
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P-value

Figure 3.3- Racial and ethnic mean changes in A1C levels over time for veterans with
depression and/or sexual dysfunction.
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Table 3.5- Fixed effect estimates for racial differences in changes in A1C levels within
diagnostic groups with covariates (Model 3)

Intercept (ref.= No diagnosis,
White)
Hypertension
CHD
Stroke
Non Hispanic Black
Depression
Sex Dysfunction
Depression/Sex Dysfunction
Time
NHB*Depression
NHB*Sex Dysfunction
NHB*Depress/Sex Dys
Black*Time
Depression*Time
Sex Dysfunction*Time
Depress/Sex Dys* Time
Depression*Black*Time
Sex Dysfunction*Black*Time
Depress/Sex Dys* Black*Time
**p < .001, *p < .05

Beta coefficient
estimate
7.14

Standard Error

P-value

0.02

<.0001****

0.27
0.15
0.0002
0.24
-0.002
0.09
-0.06
-0.04
-0.14
-0.04
0.06
0.16
0.13
-0.37
0.37
-0.43
0.01
-0.02

0.02
0.01
0.01
0.06
0.02
0.05
0.05
0.08
0.06
0.11
0.11
0.20
0.08
0.15
0.16
0.21
0.34
0.35

<.0001****
<.0001****
0.99
<.0001****
0.93
0.09
0.27
0.63
0.26
0.72
0.57
0.41
0.11
0.02*
0.02*
0.04*
0.99
0.95
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Figure 3.4- Racial and ethnic mean changes in A1C levels over time for
veterans with depression and/or sexual dysfunction with covariates.
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Table 3.6- Fixed effect estimates for curvilinear modeling of A1C values across racial
groups over time

Intercept (ref. = NHW)
Non-Hispanic Black
Time
Time2
Non-Hispanic Black*Time
Non-Hispanic Black*Time2
*p < .001

Beta coefficient
estimate
7.16
0.12
0.23
-0.33
-.032
-0.04

Standard
Error
0.01
0.02
.02
0.06
0.05
0.15

P-value
<.0001***
<.0001***
<.0001***
<.0001***
<.0001***
.81

Figure 3.5- Curvilinear Modeling of Mean changes in A1C levels over time for Black
American and White American veterans.
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Table 3.7- Fixed effect estimates for curvilinear modeling of changes in A1C values
across diagnostic groups over time (Model 1.2).

Intercept (ref. = No diagnosis)
Depression
Sexual Dysfunction
Depression/Sex Dysfunction
Time
Time2
Depression*Time
Depression*Time2
Sexual Dysfunction*Time
Sexual Dysfunction*Time2
Depress/Sex Dys*Time
Depress/Sex Dys*Time2
**p < .001, *p < .05

Beta coefficient
estimate
7.18
-0.03
0.15
0.10
0.19
-0.30
0.05
0.10
-0.30
-0.94
0.32
0.80

Standard
Error
0.02
0.02
0.05
0.05
0.06
0.18
0.06
0.19
0.11
0.35
0.11
0.36

P value
<.0001****
0.30
0.002**
0.06
0.001**
0.10
0.41
0.58
0.01*
0.01*
0.01*
0.03*

Figure 3.6- Curvilinear modeling of mean changes in A1C levels over time for veterans
with depression and/or sexual dysfunction.
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Table 3.8- Fixed effect estimates for curvilinear modeling of racial differences in A1C
values within diagnostic groups (Model 2.2).

Intercept (ref.= No diagnosis,
White)
Non Hispanic Black
Depression
Sex Dysfunction
Depression/Sex Dysfunction
Time
Time2
NHB*Depression
NHB*Sex Dysfunction
NHB*Depress/Sex Dys
Black*Time
Black* Time2
Depression*Time
Depression* Time2
Sex Dysfunction*Time
Sex Dysfunction* Time2
Depress/Sex Dys* Time
Depress/Sex Dys* Time2
Depression*Black*Time
Depression*Black* Time2
Sex Dysfunction*Black*Time
Sex Dysfunction*Black* Time2
Depress/Sex Dys* Black*Time
Depress/Sex Dys* Black* Time2
**p < .01, *p < .05

Beta coefficient
estimate
7.13

Standard
Error
0.03

<.0001****

0.25
0.01
0.15
-0.11
-0.02
0.09
-0.18
-0.05
0.08
0.18
-.031
0.13
-0.19
-0.28
-1.06
0.29
0.90
-0.47
0.62
-0.02
0.16
0.002
-0.26

0.07
0.03
0.06
0.06
0.08
0.25
0.08
0.13
0.13
0.20
0.66
0.08
0.27
0.17
0.53
0.17
0.55
0.21
0.70
0.35
1.13
0.37
1.18

0.01*
0.79
0.01*
0.07
0.93
0.71
0.02*
0.68
0.54
0.37
0.63
0.11
0.47
0.01*
0.05
0.08
0.10
0.02*
0.37
0.94
0.88
0.10
0.82
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P-value

Table 3.9- Fixed effect estimates for curvilinear modeling of racial differences in changes
in A1C levels within diagnostic groups with covariates (Model 3.2)

Intercept (ref.= No diagnosis,
White)
Hypertension (ref.= HiBP)
CHD (ref.= CHD)
Stroke (ref.= Stroke)
Non Hispanic Black
Depression
Sex Dysfunction
Depression/Sex Dysfunction
Time
Time2
NHB*Depression
NHB*Sex Dysfunction
NHB*Depress/Sex Dys
Black*Time
Black* Time2
Depression*Time
Depression* Time2
Sex Dysfunction*Time
Sex Dysfunction* Time2
Depress/Sex Dys* Time
Depress/Sex Dys* Time2
Depression*Black*Time
Depression*Black* Time2
Sex Dysfunction*Black*Time
Sex Dysfunction*Black* Time2
Depress/Sex Dys* Black*Time
Depress/Sex Dys* Black* Time2
**p < .01, *p < .05

Beta coefficient
estimate
7.14

Standard
Error
0.03

<.0001*

0.27
0.15
0.001
0.25
0.01
0.15
-0.11
-0.04
0.05
-0.18
-0.05
0.08
0.18
-.030
0.14
-0.17
-0.27
-1.03
0.28
0.90
-0.47
0.60
-0.04
0.15
0.03
-0.24

0.02
0.01
0.01
0.07
0.01
0.06
0.06
0.08
0.25
0.08
0.13
0.13
0.20
0.66
0.08
0.27
0.17
0.53
0.17
0.55
0.21
0.70
0.35
1.13
0.37
1.19

<.0001***
<.0001***
0.96
0.0004***
0.79
0.01*
0.07
0.61
0.84
0.02*
0.68
0.53
0.37
0.65
0.09
0.52
0.11
0.05
0.10
0.10
0.03*
0.39
0.90
0.89
0.94
0.84
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CHAPTER 4
DISCUSSION
This study was designed to address gaps in diabetes literature by testing racial and
ethnic differences in the effects of sexual dysfunction and depression on glycemic control
over time. Given the high prevalence of diabetes among veterans, this study examined
research questions using a sample of veterans. To the best of this author's knowledge,
this study was one of the first investigations designed to examine racial and ethnic
differences in sexual dysfunction among men with diabetes. A strength of this
investigation was the testing of both linear and curvilinear relationships for racial and
ethnic differences in glycemic control and the impact of depression and sexual
dysfunction on glycemic control over time. This is an important contribution to the
literature since existing research appears to reflect tests of linear relationships. Quadratic
modeling was found to be a better fit for analyses examining racial and ethnic differences
in A1C levels over time, as well as for analyses examining differences in A1C levels over
time between the four diagnostic groups. However, quadratic model was not found to be
a better fit for analyses examining racial and ethnic differences in the impact of
depression and/or sexual dysfunction on glycemic control over time.
Explanation of Findings
Racial Differences in the Prevalence of Depression.
It was expected that the results of testing Hypothesis 1 would reveal racial and
ethnic differences in rates of depression among veterans with diabetes, specifically that
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White American veterans would have higher rates of depression than Black American
veterans, which would be consistent with existing literature. The results of this study
revealed significant racial and ethnic differences in prevalence of depression among this
national sample of veterans with diabetes, with White American veterans exhibiting
higher rates of depression than Black American veterans. These findings could be a
reflection of racial differences in the detection and diagnosis of depression seen among
Black and White Americans in the general population. Research suggests that Black
Americans tend to endorse more somatic rather than affective symptoms of depression
(Baker, Okwumabua, Philipose, & Wong, 1996; Brown, Schulberg, & Madonia, 1996;
Das, Olfson, McCurtis, & Weissman, 2006), which could reduce accurate detection and
diagnosis of depression among Black American veterans with diabetes. Lower rates of
depression among Black American veterans could also be indicative of lower rates of
reporting due to culturally-specific beliefs and attitudes about depression. Egede (2002)
found that perceived stigma and misconceptions about the etiology of depression among
Black Americans with diabetes were significant barriers to this population seeking
treatment for depression or adhering to treatment recommendations. Beliefs that
depression is due to “personal weakness” or “self-pity” are not only barriers to treatment,
but can also prevent Black Americans from disclosing depressive symptoms to their
health care providers (Egede, 2002). It should be noted that while these findings were
significant, the small effect sizes for the analyses (phi = .02) may suggest that the overall
size of the effect may be smaller. Additional research is needed to determine overall
clinical significance.
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Racial Differences in Prevalence of Sexual Dysfunction
It was expected that the test of Hypothesis 2 would reveal racial and ethnic
differences in rates of sexual dysfunction, with Black American veterans with diabetes
possessing higher rates. The results of this study supported this hypothesis, with Black
American veterans exhibiting higher rates of sexual dysfunction than White Americans
veterans. Existing literature suggest that Black Americans report more problems with
sexual dysfunction compared to White Americans (Laumann, et. al, 1999). Existing
literature also indicates that men with diabetes more likely to have erectile dysfunction
than men who do not have diabetes (NDIC, 2008). Therefore, it seems possible that
Black American veterans with diabetes would be at greater risk for developing sexual
dysfunction when compared to White American veterans. Also, Black American veterans
had higher A1C levels compared to White American veterans, which suggest that they
are at greater risk for developing other diabetes-health related complications. It is also
possible that higher rates of sexual dysfunction among Black American veterans could be
indicative of depression. As previously mentioned, Black American men tend to report
more somatic symptoms of depression and may be more likely to report difficulties with
sexual dysfunction rather than depressed mood. Additional research examining a possible
relationship between the symptom presentation of depression and sexual dysfunction for
Black American men is needed.
Linear and Quadratic Modeling of Racial Differences in Glycemic Control over Time
Based on existing literature, it was expected that longitudinal racial and ethnic
differences in A1C levels would be found, with Black American veterans having higher
A1C levels compared to White American veterans over time. Linear modeling results for
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this study revealed that while A1C levels for Black American veterans started at higher
levels compared to White American veterans, A1C levels gradually increased for White
American veterans and decreased for Black American veterans as they grew older. The
linear model for changes in A1C levels over time suggested that A1C levels would
continue to increase for White American veterans as they grew older and continue to
decrease for Black American veterans as they grew older. However, improvement in
goodness-of-fit testing revealed that changes in A1C levels over time between Black and
White American veterans were better understood as a quadratic relationship rather than a
linear relationship.
The findings for the quadratic modeling were similar to the findings for the linear
model, such that A1C levels started higher and decreased for Black American veterans
and A1C levels started lower and increased for White American veterans. However, the
quadratic modeling provided more specific information about the different patterns of
change in A1C levels between Black and White American veterans. Specifically, the
linear model did not capture the peak in A1C levels for Black American veterans before
they began to decrease, nor did the linear model capture the peak/plateau of A1C levels
for White American veterans at a later age compared to Black American veterans.
Existing research suggests that there are three factors that independently predict change
in A1C levels over time. Specifically, older age and having diabetes longer significantly
predict decreases in A1C levels over time, while co-morbid health conditions
significantly predict increases in A1C levels over time (Fisher, Mullan, Arean, Glasgow,
Hessler, & Masharani, 2010). These differing patterns of change in A1C levels for Black
and White American veterans suggested that Black American veterans may have been
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diagnosed with diabetes at an earlier age than White American veterans, and thus their
A1C levels began to decrease and stabilize at an earlier age as well. These findings also
suggested that White American veterans may continue to have difficulties reaching
stabilized A1C levels as they get older, which could be complicated by co-morbid health
conditions related to the natural process of aging. Findings for a recent population-based
study found no racial and ethnic differences in age of diagnoses of diabetes; however, it
was noted that racial and ethnic differences in age of diagnosis were found in previous
population-based studies, with Black Americans being diagnosed at younger ages than
White Americans (Koopman, Mainous, Diaz, & Geesey, 2005). This study’s results could
be a reflection of this pattern.
It is important to note that A1C levels for White American veterans were still
lower than those of Black American veterans overall and even peaked at a lower A1C
level than Black American veterans, suggesting that they may be able to maintain
glycemic control for a longer period of time than Black American veterans. These
findings were partially consistent with existing research suggesting that Black Americans
tend to have higher A1C levels than White Americans (Egede et al, 2010; Fan, et al.,
2006; Saydah, et al., 2007; Suh, et al., 2010). However, this study’s findings revealed
that as both Black and White American veterans grew older, the differences in A1C
levels seemed to disappear, such that both groups were trending towards lower A1C
levels and improving glycemic control.
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Linear and Quadratic Modeling of Longitudinal Impact of Depression and Sexual
Dysfunction on Glycemic Control
It was expected that veterans with diabetes experiencing depression and/or sexual
dysfunction would have higher A1C levels over time compared to veterans with diabetes
with neither disorder. Linear modeling results revealed that veterans diagnosed with only
sexual dysfunction had significantly different levels and rates of change in A1C levels as
they grew older. Specifically, veterans with sexual dysfunction had higher A1C levels
than veterans with no diagnosis, but A1C levels for veterans with sexual dysfunction
decreased as they grew older and increased for veterans with no diagnosis.
However, improvement in goodness-of-fit testing revealed that changes in A1C
levels over time between veterans diagnosed with depression and/or sexual dysfunction
were better understood as a quadratic relationship rather than a linear relationship.
Similar to the linear modeling results, quadratic modeling results also revealed a
significant impact of sexual dysfunction on glycemic control, such that A1C levels for
veterans with sexual dysfunction started higher, but decreased with age relative to A1C
levels for veterans with no diagnosis starting lower and increasing with age. Quadratic
modeling provided more specific information about these changes in A1C levels over
time. Specifically, compared to mean A1C levels for veterans with no diagnosis, mean
A1C levels for veterans with sexual dysfunction started higher, peaked, and then began to
decrease as they grew older. Given research suggesting that having diabetes longer is a
significant predictor of decreasing A1C levels (Fisher et al., 2010), it seems possible that
veterans diagnosed with sexual dysfunction are potentially diagnosed with diabetes at a
younger age compared to veterans with no diagnosis, so their A1C levels potentially
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peaked and began to decrease at a younger age. A sexual dysfunction diagnosis at a
younger age can have a significant psycho-social impact on how individuals with
diabetes manage their illness. Specifically, sexual dysfunction can impact mood and
decrease motivation for individuals with diabetes to adhere to strict diet and exercise
regimens necessary to maintain health blood sugar levels, thus decreasing glycemic
control. A sexual dysfunction diagnosis can also serve as an indicator of poor glycemic
control. It may be reflective of more difficulties with neuropathic issues, which are likely
more severe for veterans with higher A1C levels, or poor glycemic control. The
downward trend in A1C levels among veterans diagnosed with sexual dysfunction could
be related to having the diagnosis for a long period of time and therefore having a longer
period to treat and learn to better manage their diabetes and any difficulties with sexual
dysfunction.
Quadratic modeling results also revealed a moderately significant impact of comorbid depression/sexual dysfunction on glycemic control. A1C levels for veterans with
both depression and sexual dysfunction followed a similar gradually increasing trend as
veterans with no diagnosis, but seemed to peak/plateau at a slightly higher A1C level
than veterans with no diagnosis. Given research indicating that having a number of health
complications in addition to diabetes is related to increasing A1C levels over time (Fisher
et al., 2012), is it possible that the additional struggles with depression and sexual
dysfunction makes managing diabetes somewhat more difficult for this diagnostic group,
leading in to slightly higher A1C levels compared to veterans with no diagnosis.
However, it should also be noted that while these findings were significant, the small
mean A1C differences between veterans with both depression and sexual dysfunction
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(7.25% at age 74) and veterans with no diagnosis (7.20% at age 74) suggest that the
overall size of the effect may be smaller. Additional research is needed to determine
overall clinical significance.
Linear and Quadratic Modeling of Racial and Ethnic Differences on Impact of
Depression and Sexual Dysfunction on Glycemic Control over Time
This study also explored possible racial and ethnic differences in the effects of
depression and sexual dysfunction on glycemic control over time. Linear modeling
results indicated that Black American veterans with depression had higher A1C levels
that decreased as they grew older, whereas White American veterans with depression had
lower A1C levels that increased as they grew older. These findings were maintained after
controlling for other illnesses significantly associated with diabetes, namely
hypertension, heart disease, and history of stroke. Improvement in goodness-of-fit testing
indicated that the quadratic modeling for this analysis, with and without the covariates,
was not a better fit for the data when compared to linear modeling. The results of the
linear modeling seem to follow the same overall trend found in racial differences in mean
A1C change over time, specifically Black American veterans having higher A1C levels
that decreased and White American veterans having lower A1C levels that increased as
they grew older. Given that research on the impact of depression on A1C levels suggest
only small to moderate effects over time (Lustman et al, 2000), these significant
differences in mean A1C change over time among this sample of veterans with
depression, suggests that aforementioned racial differences in A1C change patterns may
persistent among Black and White American veterans with depression.
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Study Implications
Although 50% of this sample of veterans had optimal A1C levels below 7%, this
still indicates that there is a large portion of veteran with diabetes that may have some
difficulty achieving glycemic control. An important finding of this study is that A1C
levels vary by race and by diagnostic group, with Black American veterans and veterans
with sexual dysfunction having the most significant changes in A1C as they grew older.
These results also indicated that the changes in A1C levels and for Black and White
American veterans and veterans with sexual dysfunction are best represented by
quadratic modeling vs. linear modeling. For some of this study’s analyses, the quadratic
modeling provided more specific information regarding the trend of change in A1C
levels, as it better captured changes in A1C levels that may naturally occur the longer a
person has diabetes. These results also revealed that tracking changes in A1C levels as a
person grows older can highlight important role of age on a person’s ability to manage
their diabetes. These findings suggest that future studies examining factors impacting
changes in glycemic control over time should explore possible curvilinear trajectories for
changes in A1C levels, as well as model time as a representation of age to best
understand glycemic control the longer a person has diabetes and as they grow older.
Many studies have explored a number of factors potentially impacting an
individual’s ability to achieve and maintain glycemic control, including depression and
sexual dysfunction. The existing literature on the impact of depression or sexual
dysfunction on glycemic control is mixed, with some studies reporting significant
differences in glycemic control between individuals with and without depression or
sexual dysfunction and others reporting no differences in glycemic control. Findings
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suggest that diagnoses of depression and/or sexual dysfunction may significantly impact
the ability of veterans to achieve glycemic control, and are important factors to consider
when assessing a patient’s ability to effectively manage their diabetes.
It seems particularly important to acknowledge the potential biopsychosocial
impact of sexual dysfunction as it relates to glycemic control. A sexual dysfunction
diagnoses could simply be a reflection of poor glycemic control, such that individuals
with poor glycemic control are at greater risk for developing diabetes-related health
complications, such as sexual dysfunction. However, a sexual dysfunction diagnosis
could also have significant psychosocial consequences related to being unable to perform
sexually, including decreased sense of self-worth and relationship difficulties. Given
research findings suggesting a reciprocal relationship between sexual dysfunction and
depression, in that the presence of either one of these conditions may trigger or
exacerbate the other (Kennedy & Razvi, 2009), a diagnosis of sexual dysfunction could
be related to psychological distress, and perhaps depression. Negative moods associated
with this distress can lead to a reduction in overall mind-body functioning manifesting
behaviorally as poor adherence to diet, exercise, and medication regiments required to
maintain healthy blood sugar levels and achieve glycemic control.
Given the mixed findings in the literature regarding the impact of depression on
glycemic control, this study’s findings highlight the possibility that this relationship could
be mediated by difficulties with sexual dysfunction. Additional research exploring the
impact of depression and sexual dysfunction on glycemic control is needed. Also, given
this study’s findings of significant improvements in glycemic control as veterans with
sexual dysfunction grew older, additional research is needed to explore additional factors,

52

other than age of diabetes diagnosis, that may be contributing to reduced A1C levels as
they age, such as differences in diabetes treatment (e.g., veterans with sexual dysfunction
may receive more medical attention, be on higher doses of insulin, or pharmacological
treatment of the sexual dysfunction improves motivation and ability to manage diabetes,
etc.).
To further increase understanding of the impact of depression on glycemic
control, this study’s results suggest considering race as having an important influence on
the relationship. Findings generally suggest that Black American veterans may struggle
with higher A1C levels during their journey to achieve glycemic control when compared
to White American veterans, but they appear to reach a turning point and start down the
path of better controlling their diabetes at an earlier age compared to White American
veterans. This implies that although White American veterans may have lower A1C
levels to manage compared to Black American veterans, they are still at less than optimal
A1C levels and may stay at these levels for longer periods of time before start down the
path of better controlling their diabetes. This implies that treatment planning for White
American veterans with diabetes may need to factor in the age, specifically the potential
to develop health complications related to aging (e.g., sensory decline, reduced cognitive
functioning, reduced physical functioning, etc.), and how these factors may further
impact the veteran’s ability to achieve glycemic control. This study’s findings indicating
racial differences in glycemic control among veterans with depression, suggest that
depression may impact Black and White American veterans differently, given their
different paths to achieving glycemic control. For example, depression may be more
severe and have more of an impact on glycemic control for older White American
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veterans with diabetes, causing their A1C levels to gradually increase as they age.
Additional research is needed to explore the possible moderation effects of race on the
relationship between depression severity and glycemic control.
In general, this study’s findings highlight the overall importance of better
understanding of the impact of emotional or psychological distress on a veteran’s ability
to manage his diabetes. Increased attention and understanding of psychological issues can
be achieved by health care providers working together with behavioral health specialists.
Health care models that emphasize a multi-disciplinary approach to health care can be an
effective method of helping veterans with diabetes manage their illness as well as manage
co-morbid emotional or psychological issues. Another way to obtain a better sense of the
impact of psychological and emotional distress on glycemic control among veterans is to
assess specifically for diabetes-related stress as opposed to depression. Fisher and
colleagues (2010) analyzed cross-sectional and longitudinal data for a relationship
between major depressive disorder and diabetes distress. They found that emotional
distress specifically tied to diabetes and its management has both cross-sectional and
longitudinal relationships with A1C, whereas MDD had no impact on glycemic control
(Fisher et al., 2010). The authors suggested the relationship between diabetes-specific
distress and glycemic control is bidirectional, such that high levels of diabetes distress
can influence self-management and medication adherence with subsequent effects of
glycemic control; on the other hand, poor glycemic control can lead to distress which
could subsequently influence diabetes management. The results of this study suggest that
assessing for diabetes distress may be informative for treatment planning among veterans
diagnosed with diabetes.
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Study Limitations
While this study has important strengths, there are a number of study limitations
that can be improved upon by future studies. One such limitation is that this study was
designed to test only quadratic trajectories for factors potentially impacting changes in
glycemic control. A test for a quadratic trajectory only assesses for one inflection point (a
peak or a valley), but the pattern of change in A1C level could have multiple peaks and
valleys over an individual’s lifetime. More complex forms than quadratic (e.g., cubic)
were not tested due to possible inflation in the number of terms given the complexity of
this study’s proposed questions. Future studies could assess the possibility of more
complex trajectories for change in glycemic control on more simplified models with
fewer predicators.
Despite the statistical significance for these analyses, it is important to note that
mean differences in A1C levels did not appear to be clinically significant when compared
to estimates of mean differences between members of racial and ethnic minority groups
and White Americans found in the diabetes literature, namely 0.65% corresponding to a
moderate effect size of 0.31 (Kirk et al., 2005). However, the design of the current study
is unique compared to the designs of the studies reporting racial and ethnic differences in
glycemic control, making it clinical significance of this study’s findings difficult to
compare to existing standards in the literature. Specifically, most studies utilize crosssectional designs as opposed to longitudinal designs, limiting the ability of these study’s
authors to make inferences about racial and ethnic differences in glycemic control over
time. Also, to this author’s knowledge there are no existing longitudinal studies
examining changes in A1C levels as a person with diabetes grows older. This study’s
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findings show that differences in A1C levels between Black and White American
veterans disappear as they increase in age, highlighting the importance of age in the
pattern of change in A1C levels. Furthermore, many of the studies comparing glycemic
control between Black and White Americans had both groups reporting A1C levels in the
uncontrolled range (> 8%), potentially contributing to a higher mean difference. Given
these differences, the currently literature may not provide sufficient information on which
to base clinical significance of this study’s findings.
Due the demographic characteristics of the study’s sample, the study’s results
may have limited generalizability. For one, prior to removing females and members of
racial and ethnic groups other than non-Hispanic Black and non-Hispanic White for
generalizability purposes, the original study sample did not appear to include non-White
Hispanics. Given the documented prevalence of diabetes among this population as well
as research indicating possible difficulties with sexual dysfunction among non-White
Hispanics, this would have been an important population to include in this studies
analyses, and their absence from the sample may have significantly impacted the results.
It is possible than non-White Hispanics appeared to be excluded from the final study
sample due to a coding error in the VA patient database that led to non-White Hispanics
being categorized as non-Hispanic White, non-Hispanic Black, or Native American.
Given the growing non-White Hispanic population in the U.S., future research examining
racial and ethnic differences in glycemic control should be sure to included non-White
Hispanic populations, as diabetes and related health issues significantly impacts this
group.
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Generalizability of results to the general population may also be limited due to
using a veteran sample, specifically a veteran sample who receives their health care
services from a VA medical center. Income requirements must be met in order for
veterans to qualify for VA services, so the population receiving health care services at a
VA medical center tends to be older males of low SES, and with more co-morbid health
conditions. Veterans receiving services at a VA medical center may also have more comorbid mental health issues in addition to depression, including posttraumatic stress
disorder, psychotic disorders, and substance abuse. While the unique qualities of this
study’s population highlight the importance of conducting more research specifically
addressing the needs of veterans who receive their care at the VA, it would also be
important to replicate this study using a non-veteran sample or conduct comparison
studies to capture potential population differences in factors that influence glycemic
control.
Another study limitation was the use of diagnoses to define depression. A
diagnosis of depression is less meaningful than actual measurements of depression over
time and does not reflect a level of severity. Furthermore, the use of depression diagnoses
associated with billable clinical encounters may have inflated this study’s prevalence of
depression, possibly misrepresenting the number of veterans with depression. Almost
90% of veterans in this study’s sample had at least one billable encounter that included a
depression diagnosis. Such a huge proportion hinders the study’s statistical power to
detect significant differences in mean A1C levels between the diagnostic groups. Future
VA studies should assess depression by using measures such as the Patient Health
Questionnaire-9 (PHQ-9) scores or Beck Depression Inventory (BDI) scores rather than
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diagnoses (Beck, Steer, Ball, & Ranieri, 1996; Spitzer, Kroenke, & Williams, 1999). The
use of such measures would allow for a better understanding of the effect of depression
on A1C levels over time.
While this study excluded veterans with schizophrenia and bipolar disorder, other
common psychological disorders found in a veteran population were not screened or
controlled for, namely posttraumatic stress disorder and substance abuse. It is possible
that these disorders potentially increase A1C levels and negatively influence the efforts of
veterans with diabetes in achieving glycemic control. I also did not screen for veterans
who were receiving disability compensation from the VA based on their presumed
exposure to Agent Orange or other herbicides, as this information was not available in the
database. Previous literature has demonstrated a relationship between dioxin (the primary
contaminant in Agent Orange and other herbicides) exposure and increased insulin
resistance, the precursor to type 2 diabetes (Henriksen, Ketchum, Michalek, & Swaby,
1997). Therefore, veterans exposed to dioxin may have a biological susceptibility to
developing type 2 diabetes, which could have a negative impact on A1C levels. Future
studies should explore the effects of psychological disorders and biological susceptibility
on glycemic control.
Conclusion
Given the ever-increasing prevalence of diabetes in the U.S. and the particularly
high prevalence of diabetes among members of racial and ethnic minority groups and
veteran populations, understanding the factors impacting diabetes-related health
outcomes seems crucial to the effective treatment of diabetes in these populations. This
study highlighted the importance of understanding and managing psychological factors
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related to chronic illness, and the need to include assessment and treatment of mental
health issues as an integral part of diabetes management strategies for veterans,
particularly for veterans whose health outcomes are more significantly impacted by
psychological distress. This study also highlighted the potential importance of a
biopsychosocial approach to understanding individual health and the potential utility of a
multidisciplinary approach to health care. Continuing to expand literature in this area
could provide increased understanding of the relationship between physical and mental
health issues and continue to inform the most effective methods for improving overall
individual health.
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